Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-05-19 @ 8:46 AM
Study NCT ID:
NCT05507658
Status:
COMPLETED
Last Update Posted:
2025-11-28
First Post:
2022-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma
Sponsor:
Xijing Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Locally Advanced Gastric Adenocarcinoma | View |
Keywords: